Literature DB >> 15671084

Cardiovascular disease and global health: threat and opportunity.

Henry Greenberg1, Susan U Raymond, Stephen R Leeder.   

Abstract

The transition in global health from infectious to chronic disease, especially cardiovascular disease, poses a threat to the economies of the less developed world. As a more sophisticated workforce becomes a highly valued and harder-to-replace economic investment, the increasing prevalence of cardiovascular risk factors becomes a threat to economic development. The next two decades offer a critical period for intervention to blunt the impact of these diseases. The response of the global assistance community has been inadequate and without impact. A new global health assistance paradigm is needed to support long-term prevention strategies to combat this epidemic.

Entities:  

Mesh:

Year:  2005        PMID: 15671084     DOI: 10.1377/hlthaff.w5.31

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  4 in total

1.  Socioeconomic inequality in the prevalence of noncommunicable diseases in low- and middle-income countries: results from the World Health Survey.

Authors:  Ahmad Reza Hosseinpoor; Nicole Bergen; Shanthi Mendis; Sam Harper; Emese Verdes; Anton Kunst; Somnath Chatterji
Journal:  BMC Public Health       Date:  2012-06-22       Impact factor: 3.295

2.  Prevalence of cardiovascular risk factors in a middle-income country and estimated cost of a treatment strategy.

Authors:  Pascal Bovet; Conrad Shamlaye; Anne Gabriel; Walter Riesen; Fred Paccaud
Journal:  BMC Public Health       Date:  2006-01-19       Impact factor: 3.295

3.  Non-communicable diseases and global health governance: enhancing global processes to improve health development.

Authors:  Roger S Magnusson
Journal:  Global Health       Date:  2007-05-22       Impact factor: 4.185

4.  The prevalence and distribution of non-communicable diseases and their risk factors in Kasese district, Uganda.

Authors:  Charles Kiiza Mondo; Marcel Andrew Otim; George Akol; Robert Musoke; Jackson Orem
Journal:  Cardiovasc J Afr       Date:  2013-04       Impact factor: 1.167

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.